Fatty acids and type 2 diabetes study
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at how free fatty acids affect people with type 2 diabetes or pre-diabetes. You may be able to join if you are overweight, have high blood sugar, and are not on certain diabetes medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your BMI is between 25 and 50.
- You have type 2 diabetes or pre-diabetes (high blood sugar).
- You are either on no diabetes medication, only taking metformin, or managing your condition with diet.
- You may have a history of heart disease, but it must not be severe or unstable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a new medicine, CS0159, to a standard diabetes drug (semaglutide) can improve liver health and blood sugar in people with fatty liver disease, obesity, and type 2 diabetes. It may help reduce liver fat and support weight loss.
This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.
This trial tests whether taking omega-3 fatty acids can reduce risk factors for developing diabetes in people with normal cholesterol but other risk factors. You might be asked to follow study visits and dietary/health restrictions for about 33 weeks.
This study tests whether the diabetes medication semaglutide can reduce inflammation and improve blood vessel health in people with type 2 diabetes who have no significant heart artery blockages. If you have diabetes and are at moderate to high heart risk but haven't had heart problems, this could help understand the medicine's extra benefits beyond blood sugar control.
This study tests if a weekly injection (semaglutide) combined with an exercise program can help reduce fat stored in the heart and muscles in people with type 2 diabetes. It may improve how well your body handles sugar and lowers your risk for heart problems.
This study tests a new medication called semaglutide (similar to Ozempic) in people with type 2 diabetes who are already taking metformin. It aims to see if this medication improves blood sugar control and may also help with weight loss.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.